171 related articles for article (PubMed ID: 31319992)
1. Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the Netherlands.
van de Ven M; Retèl VP; Koffijberg H; van Harten WH; IJzerman MJ
Lung Cancer; 2019 Aug; 134():34-41. PubMed ID: 31319992
[TBL] [Abstract][Full Text] [Related]
2. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
Wouters MW; Siesling S; Jansen-Landheer ML; Elferink MA; Belderbos J; Coebergh JW; Schramel FM
Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
[TBL] [Abstract][Full Text] [Related]
3. Treatment Patterns and Differences in Survival of Non-Small Cell Lung Cancer Patients Between Academic and Non-Academic Hospitals in the Netherlands.
van der Linden N; Bongers ML; Coupé VMH; Smit EF; Groen HJM; Welling A; Schramel FMNH; Uyl-de Groot CA
Clin Lung Cancer; 2017 Sep; 18(5):e341-e347. PubMed ID: 28347579
[TBL] [Abstract][Full Text] [Related]
4. Trends in treatment and relative survival among Non-Small Cell Lung Cancer patients in the Netherlands (1990-2014): Disparities between younger and older patients.
Driessen EJ; Aarts MJ; Bootsma GP; van Loon JG; Janssen-Heijnen ML
Lung Cancer; 2017 Jun; 108():198-204. PubMed ID: 28625635
[TBL] [Abstract][Full Text] [Related]
5. Patterns of care and outcomes for stage IIIB non-small cell lung cancer in the TNM-7 era: Results from the Netherlands Cancer Registry.
Dickhoff C; Dahele M; Smit EF; Paul MA; Senan S; Hartemink KJ; Damhuis RA
Lung Cancer; 2017 Aug; 110():14-18. PubMed ID: 28676212
[TBL] [Abstract][Full Text] [Related]
6. Impact of time-to-treatment on survival for advanced non-small cell lung cancer patients in the Netherlands: a nationwide observational cohort study.
Klarenbeek SE; Aarts MJ; van den Heuvel MM; Prokop M; Tummers M; Schuurbiers OCJ
Thorax; 2023 May; 78(5):467-475. PubMed ID: 35450944
[TBL] [Abstract][Full Text] [Related]
7. Distance from accessible specialist care and other determinants of advanced or unknown stage at diagnosis of people with non-small cell lung cancer: A data linkage study.
Tracey E; McCaughan B; Badgery-Parker T; Young J; Armstrong B
Lung Cancer; 2015 Oct; 90(1):15-21. PubMed ID: 26275475
[TBL] [Abstract][Full Text] [Related]
8. Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
Vinod SK; Chandra A; Berthelsen A; Descallar J
Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
[TBL] [Abstract][Full Text] [Related]
9. Treatment Variation of Sequential versus Concurrent Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer Patients in the Netherlands and Belgium.
Walraven I; Damhuis RA; Ten Berge MG; Rosskamp M; van Eycken L; de Ruysscher D; Belderbos JSA
Clin Oncol (R Coll Radiol); 2017 Nov; 29(11):e177-e185. PubMed ID: 28780009
[TBL] [Abstract][Full Text] [Related]
10. Variation Between Multidisciplinary Tumor Boards in Clinical Staging and Treatment Recommendations for Patients With Locally Advanced Non-small Cell Lung Cancer.
Hoeijmakers F; Heineman DJ; Daniels JM; Beck N; Tollenaar RAEM; Wouters MWJM; Marang-van de Mheen PJ; Schreurs WH;
Chest; 2020 Dec; 158(6):2675-2687. PubMed ID: 32738254
[TBL] [Abstract][Full Text] [Related]
11. Improvement in population-based survival of stage IV NSCLC due to increased use of chemotherapy.
Aarts MJ; van den Borne BE; Biesma B; Kloover JS; Aerts JG; Lemmens VE
Int J Cancer; 2015 Mar; 136(5):E387-95. PubMed ID: 25219898
[TBL] [Abstract][Full Text] [Related]
12. Treatment and survival of patients with non-small cell lung cancer Stage IIIA diagnosed in 1989-1994: a study in the region of the Comprehensive Cancer Centre East, The Netherlands.
van Dijck JA; Festen J; de Kleijn EM; Kramer GW; Tjan-Heijnen VC; Verbeek AL;
Lung Cancer; 2001 Oct; 34(1):19-27. PubMed ID: 11557109
[TBL] [Abstract][Full Text] [Related]
13. A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).
Zhou Q; Song Y; Zhang X; Chen GY; Zhong DS; Yu Z; Yu P; Zhang YP; Chen JH; Hu Y; Feng GS; Song X; Shi Q; Yang LL; Zhang PH; Wu YL
BMC Cancer; 2017 Jul; 17(1):462. PubMed ID: 28673332
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with delayed treatment initiation in an unselected cohort of patients with small-cell lung cancer.
Laerum D; Brustugun OT; Gallefoss F; Falk R; Strand TE; Fjellbirkeland L
Cancer Treat Res Commun; 2021; 29():100477. PubMed ID: 34700140
[TBL] [Abstract][Full Text] [Related]
15. The Dutch Lung Cancer Audit: Nationwide quality of care evaluation of lung cancer patients.
Ismail RK; Schramel FMNH; van Dartel M; Hilarius DL; de Boer A; Wouters MWJM; Smit HJM;
Lung Cancer; 2020 Nov; 149():68-77. PubMed ID: 32979634
[TBL] [Abstract][Full Text] [Related]
16. Population-Based Patterns of Surgical Care for Stage IIIA NSCLC in the Netherlands between 2010 and 2013.
Dickhoff C; Dahele M; de Langen AJ; Paul MA; Smit EF; Senan S; Hartemink KJ; Damhuis RA
J Thorac Oncol; 2016 Apr; 11(4):566-72. PubMed ID: 26773741
[TBL] [Abstract][Full Text] [Related]
17. Impact of Reflex EGFR/ ALK Testing on Time to Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Cheema PK; Menjak IB; Winterton-Perks Z; Raphael S; Cheng SY; Verma S; Muinuddin A; Freedman R; Toor N; Perera J; Anaka M; Victor JC
J Oncol Pract; 2017 Feb; 13(2):e130-e138. PubMed ID: 28029301
[TBL] [Abstract][Full Text] [Related]
18. Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 years.
van der Drift MA; Karim-Kos HE; Siesling S; Groen HJ; Wouters MW; Coebergh JW; de Vries E; Janssen-Heijnen ML
J Thorac Oncol; 2012 Feb; 7(2):291-8. PubMed ID: 22157366
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.
Kocher F; Hilbe W; Seeber A; Pircher A; Schmid T; Greil R; Auberger J; Nevinny-Stickel M; Sterlacci W; Tzankov A; Jamnig H; Kohler K; Zabernigg A; Frötscher J; Oberaigner W; Fiegl M
Lung Cancer; 2015 Feb; 87(2):193-200. PubMed ID: 25564398
[TBL] [Abstract][Full Text] [Related]
20. Real-World Utilization of Biomarker Testing for Patients with Advanced Non-Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals.
van de Ven M; Koffijberg H; Retèl V; Monkhorst K; Smit E; van Harten W; IJzerman M
J Mol Diagn; 2021 Apr; 23(4):484-494. PubMed ID: 33493663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
